Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1994 Dec;98(3):351–357. doi: 10.1111/j.1365-2249.1994.tb05496.x

Therapeutic advances in immunosuppression.

A W Thomson 1, J V Forrester 1
PMCID: PMC1534501  PMID: 7994898

Abstract

Immunosuppressive therapy is appropriate for the prevention or reversal of allograft rejection, and for the treatment of autoimmune disorders and allergic disease. Recent advances in our understanding of the cellular and molecular mechanisms that regulate immune responses have paralleled elucidation of the modes of action of a variety of therapeutic immunosuppressive agents, both 'old' and new. These developments have identified potential targets for more refined and specific intervention strategies that are now being tested in the clinic.

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J., Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci. 1993 Dec;14(12):436–441. doi: 10.1016/0165-6147(93)90184-l. [DOI] [PubMed] [Google Scholar]
  2. Barnes P. J., Belvisi M. G. Nitric oxide and lung disease. Thorax. 1993 Oct;48(10):1034–1043. doi: 10.1136/thx.48.10.1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beato M. Gene regulation by steroid hormones. Cell. 1989 Feb 10;56(3):335–344. doi: 10.1016/0092-8674(89)90237-7. [DOI] [PubMed] [Google Scholar]
  4. Berg L. J., Pullen A. M., Fazekas de St Groth B., Mathis D., Benoist C., Davis M. M. Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell. 1989 Sep 22;58(6):1035–1046. doi: 10.1016/0092-8674(89)90502-3. [DOI] [PubMed] [Google Scholar]
  5. Bindon C. I., Hale G., Clark M., Waldmann H. Therapeutic potential of monoclonal antibodies to the leukocyte-common antigen. Synergy and interference in complement-mediated lysis. Transplantation. 1985 Nov;40(5):538–544. doi: 10.1097/00007890-198511000-00013. [DOI] [PubMed] [Google Scholar]
  6. Brewer Y., Palmer A., Taube D., Welsh K., Bewick M., Bindon C., Hale G., Waldmann H., Dische F., Parsons V. Effect of graft perfusion with two CD45 monoclonal antibodies on incidence of kidney allograft rejection. Lancet. 1989 Oct 21;2(8669):935–937. doi: 10.1016/s0140-6736(89)90951-3. [DOI] [PubMed] [Google Scholar]
  7. Chand N., Harrison J. E., Rooney S., Pillar J., Jakubicki R., Nolan K., Diamantis W., Sofia R. D. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur J Pharmacol. 1992 Jan 28;211(1):121–123. doi: 10.1016/0014-2999(92)90273-7. [DOI] [PubMed] [Google Scholar]
  8. Chatenoud L., Thervet E., Primo J., Bach J. F. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):123–127. doi: 10.1073/pnas.91.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Collins M., Kuchroo V. K., Whitters M. J., O'Hara R. M., Jr, Kelleher K., Kubo R. T., Dorf M. E. Expression of functional alpha beta T cell receptor gene rearrangements in suppressor T cell hybridomas correlates with antigen binding, but not with suppressor cell function. J Immunol. 1990 Nov 1;145(9):2809–2819. [PubMed] [Google Scholar]
  10. Corrigan C. J., Kay A. B. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):970–977. doi: 10.1164/ajrccm/141.4_Pt_1.. [DOI] [PubMed] [Google Scholar]
  11. Dick A. D., Cheng Y. F., Liversidge J., Forrester J. V. Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis. Immunology. 1994 Aug;82(4):625–631. [PMC free article] [PubMed] [Google Scholar]
  12. Dick A. D., Cheng Y. F., McKinnon A., Liversidge J., Forrester J. V. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol. 1993 Mar;77(3):171–175. doi: 10.1136/bjo.77.3.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Djukanović R., Wilson J. W., Britten K. M., Wilson S. J., Walls A. F., Roche W. R., Howarth P. H., Holgate S. T. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis. 1990 Oct;142(4):863–871. doi: 10.1164/ajrccm/142.4.863. [DOI] [PubMed] [Google Scholar]
  14. Elliott M. J., Maini R. N., Feldmann M., Long-Fox A., Charles P., Katsikis P., Brennan F. M., Walker J., Bijl H., Ghrayeb J. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 1993 Dec;36(12):1681–1690. doi: 10.1002/art.1780361206. [DOI] [PubMed] [Google Scholar]
  15. Fairchild R. L., Kubo R. T., Moorhead J. W. DNP-specific/class I MHC-restricted suppressor molecules bear determinants of the T cell receptor alpha- and beta-chains. The V beta 8+ chain dictates restriction to either K or D. J Immunol. 1990 Oct 1;145(7):2001–2009. [PubMed] [Google Scholar]
  16. Flanagan W. M., Crabtree G. R. Rapamycin inhibits p34cdc2 expression and arrests T lymphocyte proliferation at the G1/S transition. Ann N Y Acad Sci. 1993 Nov 30;696:31–37. doi: 10.1111/j.1749-6632.1993.tb17139.x. [DOI] [PubMed] [Google Scholar]
  17. Fontes P., Rao A. S., Demetris A. J., Zeevi A., Trucco M., Carroll P., Rybka W., Rudert W. A., Ricordi C., Dodson F. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet. 1994 Jul 16;344(8916):151–155. doi: 10.1016/s0140-6736(94)92756-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Forrester J. V., Liversidge J., Dua H. S., Dick A., Harper F., McMenamin P. G. Experimental autoimmune uveoretinitis: a model system for immunointervention: a review. Curr Eye Res. 1992;11 (Suppl):33–40. doi: 10.3109/02713689208999509. [DOI] [PubMed] [Google Scholar]
  19. Forrester J. V. Uveitis: pathogenesis. Lancet. 1991 Dec 14;338(8781):1498–1501. doi: 10.1016/0140-6736(91)92309-p. [DOI] [PubMed] [Google Scholar]
  20. Fujii H., Kakinuma M., Yoshiki T., Natori T. Mapping and transcriptional properties of RT1 class II region genes. Transplantation. 1991 Aug;52(2):369–373. doi: 10.1097/00007890-199108000-00035. [DOI] [PubMed] [Google Scholar]
  21. Green D. R., Bissonnette R., Zheng H. G., Onda T., Echeverri F., Mogil R. J., Steele J. K., Voralia M., Fotedar A. Immunoregulatory activity of the T-cell receptor alpha chain demonstrated by retroviral gene transfer. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8475–8479. doi: 10.1073/pnas.88.19.8475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Green D. R., Webb D. R. Saying the 'S' word in public. Immunol Today. 1993 Nov;14(11):523–525. doi: 10.1016/0167-5699(93)90180-S. [DOI] [PubMed] [Google Scholar]
  23. Gregory C. R., Huie P., Billingham M. E., Morris R. E. Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. Transplantation. 1993 Jun;55(6):1409–1418. doi: 10.1097/00007890-199306000-00037. [DOI] [PubMed] [Google Scholar]
  24. Gulbenkian A. R., Egan R. W., Fernandez X., Jones H., Kreutner W., Kung T., Payvandi F., Sullivan L., Zurcher J. A., Watnick A. S. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Respir Dis. 1992 Jul;146(1):263–266. doi: 10.1164/ajrccm/146.1.263. [DOI] [PubMed] [Google Scholar]
  25. Higgins P. J., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol. 1988 Jan 15;140(2):440–445. [PubMed] [Google Scholar]
  26. Hoyne G. F., O'Hehir R. E., Wraith D. C., Thomas W. R., Lamb J. R. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med. 1993 Nov 1;178(5):1783–1788. doi: 10.1084/jem.178.5.1783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kahan B. D. New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation. Ther Immunol. 1994 Jan;1(1):33–44. [PubMed] [Google Scholar]
  28. Kuo C. J., Chung J., Fiorentino D. F., Flanagan W. M., Blenis J., Crabtree G. R. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature. 1992 Jul 2;358(6381):70–73. doi: 10.1038/358070a0. [DOI] [PubMed] [Google Scholar]
  29. Liu J. FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol Today. 1993 Jun;14(6):290–295. doi: 10.1016/0167-5699(93)90048-P. [DOI] [PubMed] [Google Scholar]
  30. Liversidge J., McKay D., Mullen G., Forrester J. V. Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol. 1993 Jul;149(2):315–330. doi: 10.1006/cimm.1993.1158. [DOI] [PubMed] [Google Scholar]
  31. Makowka L., Sher L. S., Cramer D. V. The development of Brequinar as an immunosuppressive drug for transplantation. Immunol Rev. 1993 Dec;136:51–70. doi: 10.1111/j.1600-065x.1993.tb00654.x. [DOI] [PubMed] [Google Scholar]
  32. Melamed D., Friedman A. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol. 1993 Apr;23(4):935–942. doi: 10.1002/eji.1830230426. [DOI] [PubMed] [Google Scholar]
  33. Miller A., Lider O., Roberts A. B., Sporn M. B., Weiner H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):421–425. doi: 10.1073/pnas.89.1.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mohapatra S., Chen Y., Takata M., Mohapatra S. S., Sehon A. H. Analysis of T-cell receptor alpha beta chains of CD8+ suppressor T cells induced by tolerogenic conjugates of antigen and monomethoxypolyethylene glycol. Involvement of TCR alpha-CDR3 domain in immunosuppression. J Immunol. 1993 Jul 15;151(2):688–698. [PubMed] [Google Scholar]
  35. Montefort S., Gratziou C., Goulding D., Polosa R., Haskard D. O., Howarth P. H., Holgate S. T., Carroll M. P. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest. 1994 Apr;93(4):1411–1421. doi: 10.1172/JCI117118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nagler-Anderson C., Bober L. A., Robinson M. E., Siskind G. W., Thorbecke G. J. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7443–7446. doi: 10.1073/pnas.83.19.7443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Nussenblatt R. B., Caspi R. R., Mahdi R., Chan C. C., Roberge F., Lider O., Weiner H. L. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol. 1990 Mar 1;144(5):1689–1695. [PubMed] [Google Scholar]
  38. O'Hehir R. E., Lamb J. R. Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8884–8888. doi: 10.1073/pnas.87.22.8884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. O'Hehir R. E., Verhoef A., Panagiotopoulou E., Keswani S., Hayball J. D., Thomas W. R., Lamb J. R. Analysis of human T cell responses to the group II allergen of Dermatophagoides species: localization of major antigenic sites. J Allergy Clin Immunol. 1993 Jul;92(1 Pt 1):105–113. doi: 10.1016/0091-6749(93)90044-g. [DOI] [PubMed] [Google Scholar]
  40. Paliogianni F., Raptis A., Ahuja S. S., Najjar S. M., Boumpas D. T. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J Clin Invest. 1993 Apr;91(4):1481–1489. doi: 10.1172/JCI116353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Peters D. H., Fitton A., Plosker G. L., Faulds D. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs. 1993 Oct;46(4):746–794. doi: 10.2165/00003495-199346040-00009. [DOI] [PubMed] [Google Scholar]
  42. Reyes J., Zeevi A., Ramos H., Tzakis A., Todo S., Demetris A. J., Nour B., Nalesnik M., Trucco M., Abu-Elmagd K. Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc. 1993 Dec;25(6):3315–3319. [PMC free article] [PubMed] [Google Scholar]
  43. Sayegh M. H., Khoury S. J., Hancock W. W., Weiner H. L., Carpenter C. B. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7762–7766. doi: 10.1073/pnas.89.16.7762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sayegh M. H., Zhang Z. J., Hancock W. W., Kwok C. A., Carpenter C. B., Weiner H. L. Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen. Transplantation. 1992 Jan;53(1):163–166. doi: 10.1097/00007890-199201000-00033. [DOI] [PubMed] [Google Scholar]
  45. Schall T. J., O'Hehir R. E., Goeddel D. V., Lamb J. R. Uncoupling of cytokine mRNA expression and protein secretion during the induction phase of T cell anergy. J Immunol. 1992 Jan 15;148(2):381–387. [PubMed] [Google Scholar]
  46. Schreiber S. L., Crabtree G. R. The mechanism of action of cyclosporin A and FK506. Immunol Today. 1992 Apr;13(4):136–142. doi: 10.1016/0167-5699(92)90111-J. [DOI] [PubMed] [Google Scholar]
  47. Sehgal S. N., Molnar-Kimber K., Ocain T. D., Weichman B. M. Rapamycin: a novel immunosuppressive macrolide. Med Res Rev. 1994 Jan;14(1):1–22. doi: 10.1002/med.2610140102. [DOI] [PubMed] [Google Scholar]
  48. Selig W., Tocker J. Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs. Eur J Pharmacol. 1992 Mar 31;213(3):331–336. doi: 10.1016/0014-2999(92)90621-a. [DOI] [PubMed] [Google Scholar]
  49. Sigal N. H., Dumont F. J. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol. 1992;10:519–560. doi: 10.1146/annurev.iy.10.040192.002511. [DOI] [PubMed] [Google Scholar]
  50. Starzl T. E., Demetris A. J., Murase N., Ildstad S., Ricordi C., Trucco M. Cell migration, chimerism, and graft acceptance. Lancet. 1992 Jun 27;339(8809):1579–1582. doi: 10.1016/0140-6736(92)91840-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Starzl T. E., Demetris A. J., Murase N., Thomson A. W., Trucco M., Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today. 1993 Jun;14(6):326–332. doi: 10.1016/0167-5699(93)90054-o. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Tarlow J. K., Blakemore A. I., Lennard A., Solari R., Hughes H. N., Steinkasserer A., Duff G. W. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 1993 May;91(4):403–404. doi: 10.1007/BF00217368. [DOI] [PubMed] [Google Scholar]
  53. Thompson H. S., Staines N. A. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol. 1986 Jun;64(3):581–586. [PMC free article] [PubMed] [Google Scholar]
  54. Thomson A. W., Carroll P. B., McCauley J., Woo J., Abu-Elmagd K., Starzl T. E., Van Thiel D. H. FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Springer Semin Immunopathol. 1993;14(4):323–344. doi: 10.1007/BF00192307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Thomson A. W., Starzl T. E. New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol Rev. 1993 Dec;136:71–98. doi: 10.1111/j.1600-065x.1993.tb00655.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Trentham D. E., Dynesius-Trentham R. A., Orav E. J., Combitchi D., Lorenzo C., Sewell K. L., Hafler D. A., Weiner H. L. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 1993 Sep 24;261(5129):1727–1730. doi: 10.1126/science.8378772. [DOI] [PubMed] [Google Scholar]
  57. Vandenbark A. A., Hashim G., Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature. 1989 Oct 12;341(6242):541–544. doi: 10.1038/341541a0. [DOI] [PubMed] [Google Scholar]
  58. Wedderburn L. R., O'Hehir R. E., Hewitt C. R., Lamb J. R., Owen M. J. In vivo clonal dominance and limited T-cell receptor usage in human CD4+ T-cell recognition of house dust mite allergens. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8214–8218. doi: 10.1073/pnas.90.17.8214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Wegner C. D., Gundel R. H., Reilly P., Haynes N., Letts L. G., Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science. 1990 Jan 26;247(4941):456–459. doi: 10.1126/science.1967851. [DOI] [PubMed] [Google Scholar]
  60. Weiner H. L., Mackin G. A., Matsui M., Orav E. J., Khoury S. J., Dawson D. M., Hafler D. A. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science. 1993 Feb 26;259(5099):1321–1324. doi: 10.1126/science.7680493. [DOI] [PubMed] [Google Scholar]
  61. Whitacre C. C., Gienapp I. E., Orosz C. G., Bitar D. M. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol. 1991 Oct 1;147(7):2155–2163. [PubMed] [Google Scholar]
  62. Wilson A. G., de Vries N., Pociot F., di Giovine F. S., van der Putte L. B., Duff G. W. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993 Feb 1;177(2):557–560. doi: 10.1084/jem.177.2.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Yssel H., Johnson K. E., Schneider P. V., Wideman J., Terr A., Kastelein R., De Vries J. E. T cell activation-inducing epitopes of the house dust mite allergen Der p I. Proliferation and lymphokine production patterns by Der p I-specific CD4+ T cell clones. J Immunol. 1992 Feb 1;148(3):738–745. [PubMed] [Google Scholar]
  64. Zhang Z. J., Davidson L., Eisenbarth G., Weiner H. L. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10252–10256. doi: 10.1073/pnas.88.22.10252. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES